当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析

瑞康医药

(002589)

  

流通市值:39.47亿  总市值:43.49亿
流通股本:13.66亿   总股本:15.05亿

瑞康医药(002589)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.52亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益570527.05万元,未分配利润31354.36万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1641885.00万元,负债1071357.95万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入6,056,194,532.514,031,665,203.82,018,758,765.188,034,367,997.33
营业总成本5,997,705,441.863,997,336,554.852,023,237,316.548,240,564,392.56
营业利润53,336,454.1643,089,470.9526,383,550.13-126,635,436.39
利润总额47,113,829.3340,186,049.6924,410,822.11-135,417,716.3
净利润52,249,021.3140,551,984.918,571,098.831,971,234.62
其他综合收益----
综合收益总额52,249,021.3140,551,984.918,571,098.831,971,234.62
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计11,566,826,407.0510,806,885,888.310,484,058,777.8511,539,092,710.53
非流动资产合计4,852,023,626.584,918,382,748.395,074,881,0035,170,213,320.95
资产总计16,418,850,033.6315,725,268,636.6915,558,939,780.8516,709,306,031.48
流动负债合计10,157,103,491.079,652,583,801.469,581,872,021.5110,761,117,605.37
非流动负债合计556,476,006.04379,111,335.11321,519,666.45311,211,432.02
负债合计10,713,579,497.1110,031,695,136.579,903,391,687.9611,072,329,037.39
归属于母公司股东权益合计5,506,126,278.25,498,345,289.355,462,962,686.335,447,793,713.64
股东权益合计5,705,270,536.525,693,573,500.125,655,548,092.895,636,976,994.09
负债和股东权益合计16,418,850,033.6315,725,268,636.6915,558,939,780.8516,709,306,031.48
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计6,652,723,709.544,151,118,736.022,177,164,203.529,250,864,499.39
经营活动现金流出小计6,641,294,038.574,141,785,160.862,231,248,746.349,168,397,807.33
经营活动产生的现金流量净额11,429,670.979,333,575.16-54,084,542.8282,466,692.06
投资活动现金流入小计468,658,637.64402,736,256.3106,456,178.961,506,388,894.9
投资活动现金流出小计202,318,342.41146,086,352.7732,169,207.09926,858,607.32
投资活动产生的现金流量净额266,340,295.23256,649,903.5374,286,971.87579,530,287.58
筹资活动现金流入小计14,973,924,857.428,935,368,955.255,942,289,521.4526,217,399,173.66
筹资活动现金流出小计15,110,791,313.198,900,592,719.525,831,685,791.8726,894,596,465.54
筹资活动产生的现金流量净额-136,866,455.7734,776,235.73110,603,729.58-677,197,291.88
汇率变动对现金及现金等价物的影响--0-924.4
现金及现金等价物净增加额140,903,510.43300,759,714.42130,806,158.63-15,201,236.64
期末现金及现金等价物余额612,845,413.16772,701,617.15602,748,061.36471,941,902.73
TOP↑